Aiste Skeberdyte

Mrs. Aiste Skeberdyte


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2017 in Cancers
Verified
Journal Article
Open access
PDF file
Jonas CicenasJonas Cicenas
Jonas Cicenas
KKKotryna Kvederaviciute
Kotryna Kvederaviciute
IMIngrida Meskinyte
Ingrida Meskinyte
EMEdita Meskinyte-Kausiliene
Edita Meskinyte-Kausiliene
ASAiste Skeberdyte
Aiste Skeberdyte
JCJonas Cicenas
Jonas Cicenas
Pancreatic cancer is a disease that has a very high fatality rate and one of the highest mortality ratios among all major cancers, remaining the fourth leading cause of cancer-related deaths in developed countries. The major treatment of pancreatic cancer is surgery; however, only 15–20% of patients are candidates for it at the diagnosis of disease. On the other hand, survival in patients, who undergo surgery, is less than 30%. In most cancers, genome stability is disturbed and pancreatic cancer is not the exception. Approximately 97% of pancreatic cancers have gene derangements, defined by point mutations, amplifications, deletions, translocations, and inversions. This review describes the most frequent genetic alterations found in pancreatic cancer.

10 December 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ASAiste Skeberdyte
Aiste Skeberdyte
ISIeva Sarapinienė
Ieva Sarapinienė
JAJan Aleksander-Krasko
Jan Aleksander-Krasko
VSVaidotas Stankevičius
Vaidotas Stankevičius
KSKęstutis Sužiedėlis
Kęstutis Sužiedėlis
SJSonata Jarmalaitė
Sonata Jarmalaitė
In the present study, we examined a hypothesis that dichloroacetate, a metabolic inhibitor, might efficiently potentiate the cytotoxic effect of salinomycin, an antibiotic ionophore, on two human colorectal cancer derived cell lines DLD-1 and HCT116. First, we performed a series of dose response experiments in the 2D cell culture by applying mono- and combination therapy and by using the Chou-Talalay method found that salinomycin in combination with dichloroacetate acted synergistically in both cell lines. Secondly, in order to recapitulate the in vivo tumor architecture, we tested various doses of these compounds, alone and in combination, in the 3D multicellular spheroid culture. The effect of combination of dichloracetate and salinomycin on multicellular spheroid size was stronger than the sum of both monotherapies, particularly in HCT116 cells. Further, we demonstrate that the synergistic effect of compounds may be related to the inhibitory effect of dichloroacetate on multidrug resistance proteins, and in contrast, it is not related to dichloroacetate-induced reduction of intracellular pH. Our findings indicate that the combination therapy of salinomycin and dichloroacetate could be an effective option for colorectal cancer treatment and provide the first mechanistic explanation of the synergistic action of these compounds.

1 March 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
ASAiste Skeberdyte
Aiste Skeberdyte
ISIeva Sarapinienė
Ieva Sarapinienė
JKJan Aleksander Krasko
Jan Aleksander Krasko
ABAušrinė Barakauskienė
Aušrinė Barakauskienė
KŽKarolina Žilionytė
Karolina Žilionytė
SJSonata Jarmalaitė
Sonata Jarmalaitė